This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Migraine and stroke

Authoring team

There is evidence that women with a self-reported history of migraine have a higher risk of ischaemic stroke (1)

  • prospective, case-controlled study of 291 women with migraine 20-44 years matched with 736 hospital controls
  • the outcome measure was self-reported history of headache - 25% of patients with stroke gave a history of migraine compared with 13% of controls. The odds ratio for ischaemic stroke was 3.54 (95% confidence interval 1.30-9.61)
  • the study showed that women with migraine have an increased risk of ischaemic stroke. There was no evidence of an increased risk of haemorrhagic stroke

A more recent systematic review and meta-analysis of observational studies (2) revealed that migraine may be a risk factor in developing stroke:

  • risk of stroke is increased in people with migraine (relative risk 2.16, 95% confidence interval 1.89 to 2.48). This increase in risk was consistent in people who had migraine with aura (relative risk 2.27, 1.61 to 3.19) and migraine without aura (relative risk 1.83, 1.06 to 3.15), as well as in those taking oral contraceptives (relative risk 8.72, 5.05 to 15.05)

Reference:

  1. BMJ 1999; 318: 13-18.
  2. Etiminan M et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330:63.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.